Search Results for: Taro with high starch
diabetic condition upregulates the insulin-secreting capacity of human induced pluripotent stem cell–derived pancreatic endocrine progenitor cells after implantation in mice taisuke mochida , ⇑ , hikaru ueno , , noriko tsubooka-yamazoe , , hideyuki hiyoshi , , ryo ito , , hirokazu matsumoto , and taro
pharmaceutical company limited, fujisawa, kanagawa, japan takeda-cira joint program for ips cell applications (t-cira), fujisawa, kanagawa, japan department of cell growth and differentiation, center for ips cell research and application (cira), kyoto university, kyoto, japan corresponding authors: taro...
https://diabetes.diabetesjournals.org/content/69/4/634
diabetic condition upregulates the insulin-secreting capacity of human induced pluripotent stem cell–derived pancreatic endocrine progenitor cells after implantation in mice taisuke mochida , ⇑ , hikaru ueno , , noriko tsubooka-yamazoe , , hideyuki hiyoshi , , ryo ito , , hirokazu matsumoto , and taro
pharmaceutical company limited, fujisawa, kanagawa, japan takeda-cira joint program for ips cell applications (t-cira), fujisawa, kanagawa, japan department of cell growth and differentiation, center for ips cell research and application (cira), kyoto university, kyoto, japan corresponding authors: taro...
https://diabetes.diabetesjournals.org/content/69/4/634